Home
Categories
EXPLORE
True Crime
Comedy
Sports
Society & Culture
Business
News
History
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/6b/1b/f1/6b1bf1d5-f24a-4fdb-9930-41a80a3f1b12/mza_9652421710894792060.jpeg/600x600bb.jpg
Bridges - Advances in Cancer Therapeutics
ADC Therapeutics
4 episodes
8 hours ago

Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma.

With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap 
and foster collaboration in patient care.

This episode is not meant to be used for medical advice and is intended for educational purposes only. Speakers were compensated by ADC Therapeutics for their time. The views expressed in this series do not reflect the views of the speaker's employer. This podcast may include discussion of investigational agents that may not be applicable or approved in 
your country.

Show more...
Medicine
Health & Fitness
RSS
All content for Bridges - Advances in Cancer Therapeutics is the property of ADC Therapeutics and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma.

With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap 
and foster collaboration in patient care.

This episode is not meant to be used for medical advice and is intended for educational purposes only. Speakers were compensated by ADC Therapeutics for their time. The views expressed in this series do not reflect the views of the speaker's employer. This podcast may include discussion of investigational agents that may not be applicable or approved in 
your country.

Show more...
Medicine
Health & Fitness
https://hosting-media.rs-prod.riverside.fm/media/podcasts/934de2f7-7887-4d79-9e25-f069280b4d63/logos/59cede84-0dba-4426-a513-d611d2382a15.jpeg
Episode 3 - Managing novel DLBCL therapies in the community - what good looks like
Bridges - Advances in Cancer Therapeutics
16 minutes 9 seconds
1 week ago
Episode 3 - Managing novel DLBCL therapies in the community - what good looks like

Integrating novel therapies like bispecific antibodies (BsAbs) and antibody drug conjugates (ADCs) into community oncology practices can be a complex process. On this episode of Bridges, Dr. Lunning and Dr. Graff speak with Dr. Iqra Choudary about how she integrated BsAbs and ADCs into her practice with a proactive multidisciplinary team, strong safety protocols, comprehensive staff training, and strategic hospital partnerships.
 
Co-hosts: Dr. Matthew Lunning, MD, University of Nebraska Medical Center, and Dr. Tara Graff, MD, Mission Cancer & Blood
Guest: Dr. Iqra Choudary, board certified in Internal Medicine, Hematology-Oncology Associates of Central New York

Bridges - Advances in Cancer Therapeutics

Bridges is a new educational podcast miniseries where co-hosts, Dr. Matthew Lunning and Dr. Tara Graff, bring together voices from across the lymphoma care spectrum. Each episode features candid conversations with a diverse range of clinicians, offering practical insights into current topics in lymphoma.

With Dr. Graff practicing in the community setting at Mission Cancer & Blood and Dr. Lunning in academic medicine at the University of Nebraska, Bridges explores the dynamic between academic and community approaches—working to close the gap 
and foster collaboration in patient care.

This episode is not meant to be used for medical advice and is intended for educational purposes only. Speakers were compensated by ADC Therapeutics for their time. The views expressed in this series do not reflect the views of the speaker's employer. This podcast may include discussion of investigational agents that may not be applicable or approved in 
your country.